Light Chain Crystalline Proximal Tubulopathy and Podocytopathy With Staining for Both Light and Heavy Chain Immunoglobulin Authors: Seoyoung Choi, Kyung Chul Moon Published: 2026 ABSTRACT ABSTRACTA 69‐year‐old male patient presented with weight loss and proteinuria. His medical history included papillary thyroid carcinoma. Laboratory findings showed proteinuria and high κ light chain levels in both urine and serum. Bone marrow aspiration revealed plasma cell myeloma of the IgA‐κ type. Kidney biopsy revealed crystal inclusions in multiple locations, including podocytes and proximal tubular epithelial cells. Immunofluorescence and immunohistochemistry revealed positive staining for κ light chain and IgA. The patient was diagnosed with light chain crystalline podocytopathy and proximal tubulopathy. Our case presented some peculiarities: positive staining for heavy‐chain IgA in addition to κ light chain and the absence of concurrent Fanconi syndrome or focal segmental glomerulosclerosis. Introduction Monoclonal gammopathy comprises a spectrum of disorders in which abnormal proteins originating from plasma cells circulate in the blood [1]. These disorders range from asymptomatic monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM). MGUS refers to monoclonal immunoglobulin accumulation in serum or urine without end‐organ damage [1]. MGUS does not require treatment from a haematological perspective but may affect other organs, such as kidneys, nerves, skin and cornea. When MGUS affects the kidneys it is called monoclonal gammopathy of renal significance (MGRS) [1]. Monoclonal immunoglobulin accumulation caused by monoclonal gammopathy may present as crystalline inclusions within the kidneys. It is classified into two categories based on whether the crystals are predominantly intracellular or extracellular. Intracellular crystal lesions are associated with slowly progressive kidney dysfunction and include light chain proximal tubulopathy (LCPT), light chain crystal‐storing histiocytosis (LC‐CSH) and light chain crystalline podocytopathy (LCCP). Extracellular crystalline lesions are associated with acute kidney injury and include crystaloglobulin‐induced nephropathy and crystalline variants of light chain cast nephropathy [2, 3]. LCCP is characterised by the presence of monoclonal immunoglobulin light chain crystalline inclusions, predominantly within podocytes. Its clinical presentation is heterogeneous and typically includes proteinuria and chronic kidney disease [3]. LCCP is rare, with approximately 50 cases reported in the literature to date [3]. LCCP often occurs concurrently with the crystalline type of LCPT [4, 5, 6]. However, LCCP is more likely to present with heavy albuminuria and concomitant focal segmental glomerulosclerosis (FSGS) than LCPT [3]. We report a 69‐year‐old man who presented with progressive weight loss and proteinuria. He was diagnosed with plasma cell myeloma of the IgA‐κ type on bone marrow biopsy, and kidney biopsy revealed LCCP and LCPT. Case A 69‐year‐old man presented with progressive weight loss and proteinuria since 2024. The patient had undergone total thyroidectomy and radioactive iodine therapy for papillary thyroid carcinoma in 2013. Initial laboratory evaluation revealed a urine protein‐to‐creatinine ratio of 2.56 g/g and a urine microalbumin level of 21.7 mg/dL. The serum free κ light chain was 428.66 mg/L and serum free λ light chain was 5.57 mg/L, yielding a κ/λ ratio of 76.96. Urine free κ light chain was 6418.48 mg/L and the urine free λ light chain was 19.16 mg/L, yielding a κ/λ ratio of 334.99. Serum IgG was 441 mg/dL, IgA 3714 mg/dL and IgM 47 mg/dL. Serum total protein was 7.6 g/dL, serum albumin 3.5 g/dL. Blood urea nitrogen and creatinine were 15 and 0.94 mg/dL, respectively. Haemoglobin was 9.0 g/dL, and the white blood cell count was 14.67 × 103/μL, platelet count 112 × 103/μL, and absolute neutrophil count 12 616/μL. Urine analysis showed 1+ albumin, 5–9 red blood cells per high‐power field, 1–4 white blood cells per high‐power field, and no bacteria, cast or crystals. Protein electrophoresis in serum showed an M spike present in the β2 fraction, consistent with monoclonal gammopathy. Immunoelectrophoresis identified monoclonal gammopathy of the IgA‐κ type. Clinically, the findings supported a diagnosis of MGRS. Renal biopsy revealed 19 glomeruli, three of which showed global sclerosis and no segmental sclerosis. The glomeruli were normal in size and showed slight focal hypercellularity involving the mesangial cells. The tubulointerstitial compartment was well‐preserved, showing only mild interstitial fibrosis and tubular atrophy. Podocytes were swollen and contained eosinophilic rod‐shaped or crystalline inclusions. Inclusions stained red with Masson's trichrome and were negative for PAS staining. These crystalline inclusions were also found in the cytoplasm of the proximal tubular epithelial cells. Crystallized tubular casts were observed in a few tubular lumens (Figure 1). Pathology findings. (A) Granular eosinophilic deposits (black arrow) are observed in podocytes cytoplasm (PAS stain × 400). (B) More deposits (white arrow) are observed in podocytes cytoplasm (HE stain × 400). (C) Similar deposits (black arrowhead) are present in proximal tubular epithelial cell cytoplasm (HE stain × 400) (D) More intracellular deposits (white arrowhead) can be seen in other tubular epithelial cells (Masson's Trichrome stain × 400). (E) Crystallized tubular casts (black stars) are observed in tubular lumens (HE stain × 400). (F) Crystallized tubular casts (white stars) (Masson's Trichrome stain × 400). Electron microscopy (EM) showed an accumulation of crystals with high electron density in the cytoplasm of podocytes, mesangial cells, glomerular endothelial cells, proximal tubular epithelial cells and peritubular capillary endothelial cells (Figure 2). Patient renal biopsy ultrastructural findings in transmission electron microscopy. (A) Numerous crystal inclusions are observed in the cytoplasm of mesangial cells (M) and podocytes (P) (× 4000). (B) Crystal inclusions in glomerular capillary endothelial cells (× 15000). (C) Crystalline deposits in proximal tubular epithelial cells (× 12 000). (D) Similar crystal inclusions in peritubular capillary endothelial cells (× 30000). Immunofluorescence (IF) showed diffuse, strong positivity for IgA and κ light chain within the glomeruli and many dot‐like or rod‐shaped positive signals in the urinary spaces, suggesting organised deposits within podocytes. Staining for IgG, IgM, C3, C1q and λ light chain was negative (Figure 3). Immunofluorescence findings. (A) Staining for kappa shows 3+ positivity in the glomeruli (original magnification × 200). Inlet shows many dot‐like or rod‐shaped positive signals in urinary space, suggesting organised deposits within podocytes. (B) Staining for gamma was negative in the glomeruli (original magnification × 200). (C) Staining for IgA shows 3+ positivity in glomeruli (original magnification × 200). Inlet shows some dot‐like positive signals in urinary space. (D) Staining for IgG was negative in the glomeruli (original magnification × 200). Immunohistochemical findings. (E) Staining for kappa light chain performed on paraffin sections shows intense staining in glomeruli, especially in podocytes. Proximal tubular epithelial cells are also positively stained. Inlet shows complete negative staining for gamma (original magnification × 400). (F) Staining for IgA showed positive staining in glomerular and peritubular capillary, with relatively weak staining in podocytes (original magnification × 400). Immunostaining showed strong positive staining for the κ light chain in glomeruli, especially in podocytes. Proximal tubular epithelial cells also showed positive staining for κ light chain. Staining for the λ light chain was negative. IgA staining was positive in the glomerular and peritubular capillaries and weak in the podocytes (Figure 3). Light chain crystalline nephropathy and proximal tubulopathy were diagnosed. Bone marrow aspiration revealed plasma cell myeloma of the IgA‐κ type. The patient was treated with elranatamab, daratumumab and lenalidomide. Serum κ and λ light chain levels were markedly reduced after treatment, and the proteinuria resolved. Follow‐up bone marrow biopsy showed a complete response. Discussion LCCP usually occurs in the setting of MGUS or multiple myeloma, although LCCP associated with lymphoma has been reported [7]. LCCP is frequently associated with FSGS and/or Fanconi syndrome, but this was not the case in our patient [3, 5, 6, 8, 9]. Light microscopy revealed crystal inclusions in podocytes and proximal tubular epithelial cells in our case. In addition, EM revealed crystals in mesangial cells and glomerular and peritubular capillary endothelial cells. Previous reports of LCCP have also shown crystal inclusions in cells other than podocytes, such as proximal tubular epithelial cells, mesangial cells and endothelial cells [3, 5, 6, 7]. Most intracellular crystal inclusions in LCCP or LCPT are associated with κ light chain [3, 10, 11, 12]. The light chains in LCCP/LCPT possess a protease‐resistant variable domain, which leads to resistance to proteolysis by lysosomal enzymes in the kidney [11, 12]. This resistance causes the formation of electron‐dense crystals. Pathogenic light chains acquire specific somatic hypermutations that create hydrophobic amino acids. The enhanced hydrophobicity of the light chain drives protein aggregation and crystal formation [3, 13]. In our case, light microscopic examination also showed crystallized tubular casts in a few tubular lumens, suggesting concurrent cast nephropathy (CN). Unlike LCCP/LCPT, the pathogenic light chains in CN are not associated with resistance to lysosomal proteolysis. Instead, high serum concentrations of the light chain overwhelm the reabsorbing capacity of proximal epithelial cells, allowing them to reach the distal tubule and bind to Tamm‐Horsfall protein (THP) to form distal tubular casts [11, 12, 14]. Pathogenic light chain in LCCP/LCPT does not tend to bind to THP [12, 14]. Therefore, LCCP/LCPT and CN rarely occur simultaneously [10, 12, 14]. Alternatively, as described in the recent RPS/IKMG consensus paper on monoclonal gammopathy–associated kidney lesions, a small amount of crystallized intratubular casts may simply reflect crystalline inclusions released from lysed or denuded tubular epithelial cells rather than true concurrent cast nephropathy. Given that the crystallized casts in our patient were very focal, they are likely to be a secondary degenerative consequence of severe crystalline tubulopathy [15]. LCCP is typically characterised by κ‐restricted crystalline inclusions, and most reported cases have shown positive staining only for the pathogenic light chain. In contrast, the present case showed positive IF and immunohistochemistry (IHC) staining for both κ light chain and IgA, suggesting that the crystal inclusions might contain both light and heavy chains. In the majority of previously reported cases, the pathogenic light chain in LCCP has been κ, and light chain had been detected on immunoelectron microscopy, IHC, IF‐F and IF‐P, each with variable sensitivity [3, 7, 16]. However, most cases either did not report staining for heavy chains or reported negative or nonspecific results for all types of heavy chains [3, 16]. Two explanations may account for the discrepancy in this case. One possibility is that the crystal inclusions contained IgA heavy chain and κ light chain. Alternatively, IgA may have been deposited outside the crystal inclusions but near the podocytes. The patient had a very high serum IgA level (3714 mg/dL), which suggested that the IgA heavy chain might have spilled over from the capillary and was not inside the crystals. In this context, pronase‐digested IF on paraffin sections can be helpful to clearly distinguish such pseudo‐positive staining. IHC supported this explanation, as IgA stained positive predominantly in the glomerular and peritubular capillaries and stained only weakly in the podocytes. As crystal formation is associated with certain characteristics of pathogenic light chains, including resistance to lysosomal proteolysis and hydrophobicity, it is unlikely that heavy chains are able to form similar types of crystal inclusions. That is, the pathogenesis suggests that the positive IgA staining in IF and IHC was due to immunoglobulin spillover from the capillaries. Conclusion We outline the case of a 69‐year‐old man with concurrent LCCP and LCPT, who showed extensive intracellular crystal formation on both light microscopy and EM. The patient presented with proteinuria and was subsequently diagnosed with plasma cell myeloma (IgA κ type). In the present case, LCCP/LCPT was not associated with FSGS or Fanconi syndrome. It is noteworthy that crystal inclusions accumulated not only in podocytes and proximal tubular epithelial cells but also in glomerular endothelial cells, mesangial cells and peritubular capillary endothelial cells. One significant difference from previously reported cases was the staining of IgA using IF and IHC. This suggests that the crystal inclusions contained heavy chains in addition to light chains. However, the pathogenesis and the patient's serum IgA level support the explanation that positive heavy chain staining is a coincidental finding and not directly associated with the formation of crystals. Funding This work was supported by the National Research Foundation of Korea, RS‐2023‐00219548. Conflicts of Interest The authors declare no conflicts of interest.